Skip to main content

$2.00 0.07 (3.36%)

High

$2.02

Low

$1.95

Trades

7

Turnover

$14,184

Volume

7,103
30 June 2023 at 3:19pm
Register to track CYC and receive email alerts.

USFDA Confirms Technegas Six Month Review Period

StockBot

416,823 posts

CYC released this announcement to the ASX on 24 April 2023, 9:48. The announcement is marked as price sensitive, and is 2 page(s) in length and 176.33kb in size.

You can view all announcements from CYC and see how they appear on a price chart on the announcements page.

At the date of this announcement, CYC was 0.000% short sold according to ASIC data. It was ranked the 627th most shorted stock on the ASX. It is now ranked as the 433rd most shorted stock on the ASX with 0.088% of total shares short sold as of the latest reported data (05 May 2025).

Other Recent Announcements from CYC
Notification of buy-back - CYC 16 May 2023, 13:36
Results of Meeting 16 May 2023, 13:34
Managing Director's Address to Shareholders 16 May 2023, 11:24
USFDA Confirms Technegas Six Month Review Period 24 April 2023, 9:48
Cyclopharm Acquires DuPharma ApS 20 April 2023, 8:20
Application for quotation of securities - CYC 18 April 2023, 11:24
Proposed issue of securities - CYC 17 April 2023, 16:44
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track CYC and receive email alerts.